Phreesia, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated May 11, 2020, reports events occurring on May 5, 2020. Phreesia, Inc., a Delaware corporation, entered into a material definitive agreement to restructure its credit facilities with Silicon Valley Bank (SVB).
Key Financial Metrics and Debt Structure
The filing details a significant revision to the Company's debt capacity and terms:
- Revolving Credit Facility: Increased from $25 million to $50 million, with an option to increase to $65 million.
- Term Loan Repayment: Approximately $20 million of the new proceeds was used to pay off an existing term loan that was scheduled to begin principal amortization in 2021.
- Repayment Terms: The new revolving line of credit requires no principal payments until termination on May 5, 2025.
- Interest Rate: Borrowings accrue interest at the greater of the prime rate or 4.50%.
- Collateral: Secured by substantially all Company assets, excluding intellectual property (subject to a negative pledge).
- Covenants: Includes a financial covenant testing Adjusted EBITDA less Capex, which is suspended if unrestricted cash exceeds $70 million.
The filing does not provide specific values for revenue, profit, cash flow, or current liquidity balances.
Material Changes Versus Prior Period
The primary material change is the expansion of the credit facility limit by $25 million and the elimination of the existing term loan's principal amortization schedule. The new agreement replaces the February 28, 2019, loan agreement, extending the maturity of the revolving credit to 2025 and altering the interest rate floor to 4.50%.
Guidance, Risks, and Contingencies
The filing does not contain forward-looking guidance, revenue outlook, or management commentary regarding future performance. However, it outlines specific contractual restrictions and risks:
- Covenant Restrictions: The agreement limits the Company's ability to incur additional indebtedness, create liens, pay dividends, make certain investments, or encumber intellectual property.
- Financial Covenant: Compliance with Adjusted EBITDA less Capex is required unless the Company maintains unrestricted cash above $70 million.
Key Facts for Investor Verification
- Verify the Company's current unrestricted cash balance to determine if the Adjusted EBITDA covenant is currently suspended.
- Confirm the utilization rate of the new $50 million revolving line of credit following the $20 million term loan payoff.
- Review the full text of the Second Amended and Restated Loan and Security Agreement (Exhibit 10.1) for detailed definitions of "Adjusted EBITDA" and specific investment limitations.
- Monitor the Company's ability to maintain the 4.50% interest rate floor relative to the prime rate.